EDSA · Edesa Biotech, Inc.
$4.78
+0.05 (+0.95%)
At close · Sep 1
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s ability to continue as a going concern is dependent on obtaining additional funding through financings, other strategic activities as well as via grants, to fund the development of its drug candidates. There can be no assurance that the Company will be successful in raising the necessary financing. These conditions indicate the existence of a material uncertainty that may cast substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$44.45M
Shares
9.64M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-27 | 58,793 | 108,719 | 167,512 | 38.0% |
| 2026-07-20 | 44,476 | 121,266 | 165,742 | 47.5% |
| 2026-07-13 | 33,820 | 90,993 | 124,813 | 52.1% |
| 2026-07-06 | 26,130 | 88,552 | 114,682 | 42.1% |
| 2026-06-29 | 39,424 | 132,559 | 171,983 | 45.0% |
| 2026-06-22 | 48,171 | 232,512 | 280,683 | 49.4% |
| 2026-06-15 | 89,888 | 277,684 | 367,572 | 42.6% |
| 2026-06-08 | 149,762 | 504,438 | 654,200 | 45.6% |
| 2026-06-01 | 178,110 | 563,141 | 741,251 | 44.6% |
| 2026-05-25 | 151,276 | 448,768 | 600,044 | 46.4% |
| 2026-05-18 | 221,185 | 1,028,449 | 1,249,634 | 49.9% |
| 2026-05-11 | 175,855 | 472,222 | 648,077 | 49.8% |
| 2026-05-04 | 251,885 | 734,482 | 986,367 | 48.9% |
| 2026-04-27 | 993,784 | 8,915,119 | 9,908,903 | 58.2% |
| 2026-04-20 | 71,372 | 499,743 | 571,115 | 48.2% |
| 2026-04-13 | 85,381 | 513,397 | 598,778 | 45.4% |
| 2026-04-06 | 59,866 | 332,742 | 392,608 | 43.2% |
| 2026-03-30 | 92,171 | 633,032 | 725,203 | 51.1% |
| 2026-03-23 | 203,710 | 1,539,875 | 1,743,585 | 55.9% |
| 2026-03-16 | 807,500 | 7,845,182 | 8,652,682 | 58.8% |
| 2026-03-09 | 960,312 | 4,516,511 | 5,476,823 | 52.3% |
| 2026-03-02 | 3,578,121 | 38,947,671 | 42,525,792 | 57.2% |
| 2026-02-23 | 6,114,048 | 88,034,069 | 94,148,117 | 61.2% |
| 2026-02-16 | 150,867 | 2,391,868 | 2,542,735 | 40.8% |
| 2026-02-09 | 23,573 | 100,320 | 123,893 | 26.7% |
| 2026-02-02 | 45,621 | 570,468 | 616,089 | 64.0% |
| 2026-01-26 | 46,126 | 317,212 | 363,338 | 51.6% |
| 2026-01-19 | 11,348 | 78,295 | 89,643 | 62.6% |
| 2026-01-12 | 4,746 | 73,930 | 78,676 | 62.6% |
| 2026-01-05 | 2,021 | 92,886 | 94,907 | 77.8% |
| 2025-12-29 | 13,178 | 223,613 | 236,791 | 63.8% |
| 2025-12-22 | 10,750 | 123,066 | 133,816 | 69.6% |
| 2025-12-15 | 5,394 | 131,033 | 136,427 | 63.6% |
| 2025-12-08 | 3,758 | 114,492 | 118,250 | 67.3% |
| 2025-12-01 | 5,638 | 100,876 | 106,514 | 64.5% |
| 2025-11-24 | 2,684 | 54,291 | 56,975 | 64.9% |
| 2025-11-17 | 4,035 | 54,174 | 58,209 | 60.2% |
| 2025-11-10 | 3,991 | 108,582 | 112,573 | 60.9% |
| 2025-11-03 | 60,446 | 303,275 | 363,721 | 52.3% |
| 2025-10-27 | 172,417 | 5,299,893 | 5,472,310 | 31.9% |
| 2025-10-20 | 9,315 | 83,370 | 92,685 | 52.5% |
| 2025-10-13 | 7,043 | 58,607 | 65,650 | 55.6% |
| 2025-10-06 | 47,749 | 320,748 | 368,497 | 68.6% |
| 2025-09-29 | 12,771 | 748,852 | 761,623 | 40.2% |
| 2025-09-22 | 3,186 | 128,560 | 131,746 | 76.0% |
| 2025-09-15 | 789 | 29,882 | 30,671 | 58.1% |
| 2025-09-08 | 571 | 18,624 | 19,195 | 75.9% |
Showing 1–47 of 47 weeks
Key facts
CIK
1540159
CUSIP
27966L306
13F (30d)
32 filings
30 filers
Visit website
Investor relations